Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

265Citations
Citations of this article
162Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Although radionecrosis has been exhaustively described in depth in the neurooncological literature, its diagnosis is still a challenging issue because its radiological pattern is frequently indistinguishable from that of tumor recurrence. This review discusses the causes of radionecrosis and the potential effect of adjuvant chemotherapy concomitant with radiotherapy on its rate and onset. The potential pitfalls in clinical studies attempting to make a differential diagnosis between radionecrosis and disease progression are also discussed. Copyright 2008 by the Society for Neuro-Oncology.

Cite

CITATION STYLE

APA

Brandes, A. A., Tosoni, A., Spagnolli, F., Frezza, G., Leonardi, M., Calbucci, F., & Franceschi, E. (2008, June). Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology. Neuro-Oncology. https://doi.org/10.1215/15228517-2008-008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free